KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.7 billion.

  • Abbott Laboratories' Shares Outstanding (Weighted Average) rose 7.31% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 7.31%. This contributed to the annual value of $1.7 billion for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Abbott Laboratories reported Shares Outstanding (Weighted Average) of $1.7 billion as of Q3 2025, which was up 7.31% from $1.7 billion recorded in Q2 2025.
  • Abbott Laboratories' Shares Outstanding (Weighted Average)'s 5-year high stood at $1.8 billion during Q2 2021, with a 5-year trough of $1.7 billion in Q1 2025.
  • In the last 5 years, Abbott Laboratories' Shares Outstanding (Weighted Average) had a median value of $1.7 billion in 2024 and averaged $1.8 billion.
  • As far as peak fluctuations go, Abbott Laboratories' Shares Outstanding (Weighted Average) surged by 44.89% in 2021, and later tumbled by 123.94% in 2022.
  • Abbott Laboratories' Shares Outstanding (Weighted Average) (Quarter) stood at $1.8 billion in 2021, then decreased by 1.24% to $1.8 billion in 2022, then dropped by 0.74% to $1.7 billion in 2023, then changed by 0.0% to $1.7 billion in 2024, then increased by 0.12% to $1.7 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.7 billion for Q3 2025, versus $1.7 billion for Q2 2025 and $1.7 billion for Q1 2025.